Valneva specialises in the development, manufacture and commercialization of vaccines. The Company’s portfolio includes vaccines for the prevention of Japanese Encephalitis and for the prevention of cholera. Valneva is also developing new vaccines to prevent Lyme disease, COVID-19 and chikungunya.